Phenoxymethylpenicillin (Betapen)
Phenoxymethylpenicillin
Ranbaxy Pharmaceutical (Pty) Ltd
Registration
- Applicant
- Ranbaxy Pharmaceutical (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Betapen 250 MG granules EACH 5 ml WHEN DILUTED CONTAINS PHENOXYMETHYLPENICILLIN POTASSIUM 250 ,0 mg | 250 mgGranules | B0203B/20.1.2/203 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Phenoxymethylpenicillin
- except when intended for the prophylaxis of rheumatic fever.
Consolidated Schedules 06 July 2026, line 7543
S3: Phenoxymethylpenicillin
- when intended for the prophylaxis of rheumatic fever.
Consolidated Schedules 06 July 2026, line 4118
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
Drag to rotate. Structure from PubChem CID 6869.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.